AI Summary
This article discusses a new drug that has been developed to prevent flu-related inflammation and lung damage. The drug can help control inflammation while still allowing the immune system to combat the virus, even when administered late in the infection process. This development could potentially lead to improved outcomes for individuals with severe cases of the flu.
Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infection.